ArticleThe journal of extra-corporeal technology2012
BioGlue in 2011: what is its role in cardiac surgery?
Article in The journal of extra-corporeal technology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03917862 (The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery), which is not on this map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery
Who cites it
30 citing papers in PubMed.
- Comparative Analysis of Adhesive Strength and Flexibility in Surgical Sealants for Cardiovascular Surgery.Annals of vascular diseases · 2026Article
- Aortic root reconstruction in acute type A aortic dissection - a simplified technique preserving aortic root geometry.Indian journal of thoracic and cardiovascular surgery · 2025Article
- Review
- Commentary: The Balloon and Glue Technique in Acute Type A Aortic Dissection: Considerations for Optimization and Clinical Application.Journal of chest surgery · 2025Article
- An aortic root abscess mimic identified by multi-disciplinary imaging review: a case report.European heart journal. Case reports · 2025Article
- Aortic lumen repair with glue-felt technique before proximal anastomosis in acute type a aortic dissection surgery.Journal of cardiothoracic surgery · 2025Article
- Polytetrafluoroethylene Felt Inlay Neomedia and Tissue Glue Do Not Prevent Reoperation in Type A Aortic Dissection.Journal of clinical medicine · 2024Article
- A thermo-sensitive hydrogel with prominent hemostatic effect prevents tumor recurrence via anti-anoikis-resistance.Journal of nanobiotechnology · 2024Article
- Inflammatory response induction as a result of BioGlue adhesive application in cardiac surgery - a review of the literature.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2024Review
- Synthetic Pressure Sensitive Adhesives for Biomedical Applications.Progress in polymer science · 2023Article
- Synthesis and Evaluation of Metal Lipoate Adhesives.Polymers · 2023Article
- Progress of tissue adhesives based on proteins and synthetic polymers.Biomaterials research · 2023Review
- Recent advances in the medical applications of hemostatic materials.Theranostics · 2023Review
- Mass Spectrometry, Structural Analysis, and Anti-Inflammatory Properties of Photo-Cross-Linked Human Albumin Hydrogels.ACS applied bio materials · 2022Article
- Sinonasal outcomes associated with the use of BioGlue® in endoscopic transsphenoidal pituitary surgery.Neurosurgical review · 2022Article
- Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends.Polymers · 2022Review
- Sterile peri-graft abscess formation following aortic replacement: A word of caution for usage of BioGlueThe International journal of artificial organs · 2021Article
- Article
- Application and outlook of topical hemostatic materials: a narrative review.Annals of translational medicine · 2021Review
- Inflammatory reaction to BioGlue™ masquerading as recurrence in patients with endometrial cancer: A report of two cases.Gynecologic oncology reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BioGlue surgical adhesive was developed as an adjunct for achieving hemostasis during cardiovascular surgery, and it was approved for use in the United States by the Food and Drug Administration in 2001. When applied to cardiovascular tissues, the glutaraldehyde and bovine serum albumin that comprise BioGlue produce strong crosslinking that bonds tissues and seals defects. These features have made BioGlue particularly well suited for preventing bleeding from fragile cardiovascular anastomoses such as those inherent in the repair of acute aortic dissection. Over the 10-year period since its approval, several studies and clinical reports have illuminated the relative risks and benefits of using BioGlue during cardiovascular operations. Understanding these merits and limitations of BioGlue is essential to ensuring its safe and effective use.
Indexed as
Identifiers
22730865PMC4557450What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.